498 related articles for article (PubMed ID: 17507609)
1. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609
[TBL] [Abstract][Full Text] [Related]
2. Gut check: can cost-effectiveness analysis help eliminate gastric cancer in Asia?
Ramsey S
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):873-4. PubMed ID: 17507608
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese.
Xie F; Luo N; Blackhouse G; Goeree R; Lee HP
Int J Technol Assess Health Care; 2008; 24(1):87-95. PubMed ID: 18218173
[TBL] [Abstract][Full Text] [Related]
4. [Cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: Markov decision analysis].
Wang Q; Jin PH; Lin GW; Xu SR; Chen J
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Feb; 24(2):135-9. PubMed ID: 12697117
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic screening for gastric cancer.
Dan YY; So JB; Yeoh KG
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer.
Shin DW; Yun YH; Choi IJ; Koh E; Park SM
Helicobacter; 2009 Dec; 14(6):536-44. PubMed ID: 19889071
[TBL] [Abstract][Full Text] [Related]
7. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R
J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
[TBL] [Abstract][Full Text] [Related]
8. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
9. Asia-Pacific consensus guidelines on gastric cancer prevention.
Fock KM; Talley N; Moayyedi P; Hunt R; Azuma T; Sugano K; Xiao SD; Lam SK; Goh KL; Chiba T; Uemura N; Kim JG; Kim N; Ang TL; Mahachai V; Mitchell H; Rani AA; Liou JM; Vilaichone RK; Sollano J;
J Gastroenterol Hepatol; 2008 Mar; 23(3):351-65. PubMed ID: 18318820
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.
You JH; Wong PL; Wu JC
Scand J Gastroenterol; 2006 Jan; 41(1):21-9. PubMed ID: 16373272
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?
Pohl H; Finlayson SR; Sonnenberg A; Robertson DJ
Aliment Pharmacol Ther; 2005 Sep; 22(6):529-37. PubMed ID: 16167969
[TBL] [Abstract][Full Text] [Related]
12. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
13. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.
Xie F; Luo N; Lee HP
World J Gastroenterol; 2008 May; 14(19):3021-7. PubMed ID: 18494053
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit analysis of Helicobacter pylori screening.
Leivo T; Salomaa A; Kosunen TU; Tuominen R; Färkkilä M; Linna M; Sintonen H
Health Policy; 2004 Oct; 70(1):85-96. PubMed ID: 15312711
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ
Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the nationwide reimbursement database.
Cheng HC; Wang JD; Chen WY; Chen CW; Chang SC; Sheu BS
Helicobacter; 2015 Apr; 20(2):114-24. PubMed ID: 25382169
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
Kwon JS; Lu KH
Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori.
Vakil N; Rhew D; Soll A; Ofman JJ
Am J Gastroenterol; 2000 Jul; 95(7):1691-8. PubMed ID: 10925969
[TBL] [Abstract][Full Text] [Related]
20. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]